Information Provided By:
Fly News Breaks for February 15, 2018
TNDM
Feb 15, 2018 | 10:28 EDT
Piper Jaffray analyst JP McKim said he is becoming more positive on Tandem Diabetes since its most recent round of financing removes its liquidity risk, and its PROLOG study data showed a 31% reduction in hypo readings without increasing hyper readings. However McKim maintained a Neutral rating on Tandem Diabetes shares, saying he needs to see another quarter of solid pump sales to become more constructive on the stock.